其他
海外大型药企转让50个ANDA产品,每个35万美元
转让背景:
1)全球TOP20药企收购美国药企后进行产品梳理,清理掉对他们来言属于低价值的产品线
2)部分产品可以安排子公司代理生成和销售
3 ) 每个项目35万美元(包含所有研发,申报和生成相关资料)
Proprietary Name | Dosage Form | Route | Strength | Approval Date |
LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN | CAPSULE, CAPSULE, DELAYED REL PELLETS, TABLET | ORAL | 500MG,N/A,N/A; N/A,500MG,N/A; N/A,N/A,30MG | 30-Aug-13 |
ASPIRIN AND DIPYRIDAMOLE | CAPSULE, EXTENDED RELEASE | ORAL | 25MG; 200MG | 18-Jan-17 |
BENAZEPRIL HYDROCHLORIDE | TABLET | ORAL | 5MG | 11-Feb-04 |
BENAZEPRIL HYDROCHLORIDE | TABLET | ORAL | 10MG | 11-Feb-04 |
BENAZEPRIL HYDROCHLORIDE | TABLET | ORAL | 20MG | 11-Feb-04 |
BENAZEPRIL HYDROCHLORIDE | TABLET | ORAL | 40MG | 11-Feb-04 |
CEFADROXIL | FOR SUSPENSION | ORAL | EQ 500MG BASE/5ML | 20-Jan-06 |
CEFUROXIME AXETIL | TABLET | ORAL | EQ 250MG BASE | 18-Oct-04 |
CEFUROXIME AXETIL | TABLET | ORAL | EQ 500MG BASE | 18-Oct-04 |
CIPROFLOXACIN HYDROCHLORIDE | TABLET | ORAL | EQ 100MG BASE | 3-Mar-05 |
CIPROFLOXACIN HYDROCHLORIDE | TABLET | ORAL | EQ 250MG BASE | 9-Jun-04 |
CIPROFLOXACIN HYDROCHLORIDE | TABLET | ORAL | EQ 500MG BASE | 9-Jun-04 |
CIPROFLOXACIN HYDROCHLORIDE | TABLET | ORAL | EQ 750MG BASE | 9-Jun-04 |
CIPROFLOXACIN EXTENDED RELEASE | TABLET, EXTENDED RELEASE | ORAL | 212.6MG; EQ 287.5MG BASE | 30-Nov-10 |
CIPROFLOXACIN EXTENDED RELEASE | TABLET, EXTENDED RELEASE | ORAL | 425.2MG; EQ 574.9MG BASE | 30-Nov-10 |
CLARITHROMYCIN | TABLET, EXTENDED RELEASE | ORAL | 500MG | 25-Aug-05 |
CLOPIDOGREL BISULFATE | TABLET | ORAL | EQ 300MG BASE | 17-May-12 |
CLOPIDOGREL BISULFATE | TABLET | ORAL | EQ 300MG BASE | 17-May-12 |
FLUCONAZOLE | TABLET | ORAL | 200MG | 29-Jul-04 |
FLUOXETINE HYDROCHLORIDE | CAPSULE | ORAL | EQ 10MG BASE | 20-May-08 |
FLUOXETINE HYDROCHLORIDE | CAPSULE | ORAL | EQ 20MG BASE | 20-May-08 |
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE | TABLET | ORAL | 10MG; 12.5MG | 3-Dec-04 |
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE | TABLET | ORAL | 10MG; 12.5MG | 16-Aug-05 |
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE | TABLET | ORAL | 20MG; 12.5MG | 3-Dec-04 |
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE | TABLET | ORAL | 20MG; 12.5MG | 16-Aug-05 |
HYDROCODONE BITARTRATE AND IBUPROFEN | TABLET | ORAL | 5MG; 200MG | Jun 23, 2010 |
LACTULOSE | SOLUTION | ORAL | 10GM/15ML | 28-Nov-07 |
LACTULOSE | SOLUTION | ORAL, RECTAL | 10GM/15ML | 21-Nov-08 |
LANSOPRAZOLE | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | ORAL | 15MG | 15-Oct-10 |
LANSOPRAZOLE | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | ORAL | 30MG | 15-Oct-10 |
LORAZEPAM | TABLET | ORAL | 0.5MG | 13-Dec-06 |
LORAZEPAM | TABLET | ORAL | 1MG | Dec 13, 2006 |
LORAZEPAM | TABLET | ORAL | 2MG | Dec 13, 2006 |
NARATRIPTAN | TABLET | ORAL | EQ 1MG BASE | 7-Jul-10 |
NARATRIPTAN | TABLET | ORAL | EQ 2.5MG BASE | 7-Jul-10 |
NEVIRAPINE | TABLET | ORAL | 200MG | May 22, 2012 |
NEVIRAPINE | TABLET, EXTENDED RELEASE | ORAL | 100MG | Jul 31, 2017 |
NEVIRAPINE | TABLET, EXTENDED RELEASE | ORAL | 400MG | Jul 31, 2017 |
OXCARBAZEPINE | TABLET | ORAL | 150MG | Dec 11, 2007 |
OXCARBAZEPINE | TABLET | ORAL | 300MG | 11-Dec-07 |
OXCARBAZEPINE | TABLET | ORAL | 600MG | Dec 11, 2007 |
OXYCODONE HYDROCHLORIDE | SOLUTION | ORAL | 100MG/5ML | 30-Aug-17 |
PERINDOPRIL ERBUMINE | TABLET | ORAL | 2MG | 10-Nov-09 |
PERINDOPRIL ERBUMINE | TABLET | ORAL | 4MG | 10-Nov-09 |
PERINDOPRIL ERBUMINE | TABLET | ORAL | 8MG | 10-Nov-09 |